Hyundai Pharmaceutical Market Cap

Hyundai Pharmaceutical has a market cap or net worth of 243.29 billion as of April 28, 2026. Its market cap has increased by 183.55% in one year.

Market Cap

243.29B

Enterprise Value

n/a

Revenue

108.14B

Ranking

n/a

PE Ratio

145.68

Stock Price

8,820.00

Market Cap Chart

Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 243.29B, an increase of 745.48%. That is a compound annual growth rate of 7.21%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	243.29B	3.17%
Dec 30, 2025	235.81B	137.66%
Dec 30, 2024	99.22B	-12.77%
Dec 28, 2023	113.76B	-14.20%
Dec 29, 2022	132.58B	-19.22%
Dec 30, 2021	164.12B	-22.93%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
HLB Pharmaceutical	247.85B
Boditech Med	244.14B
Chong Kun Dang Holdings	238.98B
CMG Pharmaceutical	268.19B
Daewon Pharmaceutical	234.27B
Samjin Pharmaceuticals	233.63B
Suheung	223.28B
BNC Korea	285.21B

Market Cap Rankings